These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18457727

  • 1. [Imatinib-induced DRESS].
    Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, Joly P.
    Ann Dermatol Venereol; 2008 May; 135(5):393-6. PubMed ID: 18457727
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.
    François H, Coppo P, Hayman JP, Fouqueray B, Mougenot B, Ronco P.
    Am J Kidney Dis; 2008 Feb; 51(2):298-301. PubMed ID: 18215707
    [Abstract] [Full Text] [Related]

  • 4. Imatinib: a designer drug, another cutaneous complication.
    Dickens E, Lewis F, Bienz N.
    Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Generalized erythema triggered by a rapid decrease of basophils in chronic myeloid leukemia treated with imatinib].
    Sugito M, Tsukada J, Higashi T, Ohta T, Matsuura A, Kubota A, Mizobe T, Mouri F, Morimoto H, Tanaka Y.
    Rinsho Ketsueki; 2005 Nov; 46(11):1226-8. PubMed ID: 16440809
    [Abstract] [Full Text] [Related]

  • 7. Livedoid skin reaction probably due to imatinib therapy.
    Martínez-González MC, del Pozo J, Yebra-Pimentel MT, Pérez M, Almagro M, Fonseca E.
    Ann Pharmacother; 2007 Jan; 41(1):148-52. PubMed ID: 17190842
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment.
    Brazzelli V, Roveda E, Prestinari F, Barbagallo T, Bellani E, Trevisan V, Rona C, Locatelli F, Zecca M, Borroni G.
    Pediatr Dermatol; 2006 Jan; 23(2):175-8. PubMed ID: 16650231
    [Abstract] [Full Text] [Related]

  • 10. Desensitization to imatinib in patients with leukemia.
    Nelson RP, Cornetta K, Ward KE, Ramanuja S, Fausel C, Cripe LD.
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):216-22. PubMed ID: 16937754
    [Abstract] [Full Text] [Related]

  • 11. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
    Khan KA, Junaid A, Siddiqui NS, Mukhtar K, Siddiqui S.
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Syndrome of inappropriate secretion of antidiuretic hormone associated with imatinib.
    Liapis K, Apostolidis J, Charitaki E, Panitsas F, Harhalakis N, Nikiforakis E.
    Ann Pharmacother; 2008 Dec; 42(12):1882-6. PubMed ID: 19017824
    [Abstract] [Full Text] [Related]

  • 14. Irreversible sensorineural hearing loss due to Imatinib.
    Attili VS, Bapsy PP, Anupama G, Lokanatha D.
    Leuk Res; 2008 Jun; 32(6):991-2. PubMed ID: 18221994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prolonged imatinib-induced myelosuppression in chronic myeloid leukaemia with an unusually long survival.
    Busuttil DP.
    Int J Lab Hematol; 2008 Feb; 30(1):68-70. PubMed ID: 18190471
    [Abstract] [Full Text] [Related]

  • 17. Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature.
    Kuraishi N, Nagai Y, Hasegawa M, Ishikawa O.
    Acta Derm Venereol; 2010 Feb; 90(1):73-6. PubMed ID: 20107730
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
    de Masson A, Bouvresse S, Clérici T, Mahé E, Saïag P.
    Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
    [Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate induced skin hypopigmentation.
    Talwar V, Doval DC, Bhatia K.
    J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.